Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
6.28
+0.32 (5.37%)
At close: Dec 19, 2025, 4:00 PM EST
6.31
+0.03 (0.48%)
After-hours: Dec 19, 2025, 7:42 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
Therapeutics for the Treatment of Metabolic Dysfunction-associated Steatohepatitis and Other Diseases
2.00M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
2.00M